Supported by

Stable CAD (Coronary artery disease)

Find all the latest content on stable coronary artery disease (stable CAD) published on this website.

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

361 results

PPG: a novel dimension in coronary physiology

24 Nov 2021

Discover the replay of this PCR Webinar on coronary physiology with B. De Bruyne, C. Collet, D. Perera and J. Sonck

PPG: a novel dimension in coronary physiology

Should we measure FFR post-PCI?

26 Oct 2021

Discover the replay of this PCR Webinar on coronary physiology with B. De Bruyne, C. Collet, D. Collison and J. Escaned

Should we measure FFR post-PCI?

How to use invasive coronary physiology in ACS patients?

23 Sep 2021

Watch the replay of this webinar on coronary physiology with F. Alfonso, T. Engstrom, T. Keeble and R. Kharbanda

How to use invasive coronary physiology in ACS patients?

How to use Invasive Coronary Physiology to assess LM disease, pre-TAVI and pre-CABG interventions?

31 Aug 2021

Watch the replay of this webinar on coronary physiology with R. Al-Lamee, E. Barbato, B. De Bruyne and N. Gonzalo

How to use Invasive Coronary Physiology to assess LM disease, pre-TAVI and pre-CABG interventions?

Coronary physiology in a modern catheter laboratory

29 Jun 2021

Watch the replay of this webinar on coronary physiology with S. B. Baptista, N. P. Johnson, N. H.J. Pijls and G. G. Toth

Coronary physiology in a modern catheter laboratory

Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI - STRENGTH Study

14 Aug 2022

The STRENGTH study is a multicentre prospective randomised trial investigating whether RenalGuard is superior to standard intravenous hydration in preventing contrast induced nephropathy in patients with chronic kidney disease (CKD) undergoing complex cardiovascular procedures.

Nicola Ryan

Reviewer

Nicola Ryan
Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI - STRENGTH Study

PCRonline @ ESC Congress 2022: the interventional cardiology perspective!

18 Jul 2022

Stay up to date with what was new and hot in interventional cardiology at the #ESCCongress 2022!

PCRonline @ ESC Congress 2022

Ultrathin, biodegradable-polymer sirolimus-eluting stent vs thin, durable-polymer everolimus-eluting stent

06 Jul 2022

The CASTLE trial is a randomised multicentre prospective non-inferiority trial comparing ultra-thin strut bioresorbable polymer and thin strut durable polymer drug eluting stents implanted with intracoronary imaging guidance.

Nicola Ryan

Reviewer

Nicola Ryan
Ultrathin, biodegradable-polymer sirolimus-eluting stent vs thin, durable-polymer everolimus-eluting stent

Distal versus conventional radial access for coronary angiography and intervention (DISCO RADIAL)

13 Jun 2022

The DISCO RADIAL trial sought to assess the efficacy and safety of distal radial access (DRA) compared with conventional transradial access (TRA) with systematic implementation of best prevention methods for the reduction of radial artery occlusion (RAO).

Reviewer

Aaysha Cader

Reviewer

Ali Nazmi Calik
Distal versus conventional radial access for coronary angiography and intervention (DISCO RADIAL)

Polymer-based versus polymer-free stents in high bleeding risk patients: final 2-year results from Onyx ONE

08 Jun 2022

The results of this study show that at 2-year follow-up HBR patients undergoing PCI with a polymer-based zotarolimus-eluting stent & 1-month DAPT had similar outcomes in terms of both safety & efficacy to those with a polymer-free biolimus A9-coated stent.

Nicola Ryan

Reviewer

Nicola Ryan
Polymer-based versus polymer-free stents in high bleeding risk patients: final 2-year results from Onyx ONE